Abstract
Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build-up of fat in the liver. The goal of the study was to determine the link between lipid damage (MDA), enzymatic and non-enzymatic antioxidants, and various biochemical indicators in patients with NAFLD who had diabetes and obese adults. This study included comparison 100 patients and healthy control group, aged 18 to 75 years while BMI range from 15.9 to 50.9 Kg/m2. Enzymatic antioxidants (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx)); non-enzymatic antioxidants (GSH, vit E and direct and total bilirubin); lipid damage (malondialdehyde (MDA)), and biochemical markers (liver enzyme (ALT, AST & ALP), glucose, Albumin and lipid profile in the serum samples were measured. The NAFLD with DM and obese adult showed increasing of glucose, BMI, ALT, AST, ALP, T. CHOL, LDL, TG, VLDL, SOD and CAT levels excepted HDL. It showed a decreasing. Whereas decrease of Vitamin E and ALB levels compared to control group. Our findings show that the serum enzymatic anti-oxidant, non-enzymatic anti-oxidant, dyslipidemia and liver disfunction and vitamin E decrease are tightly and independently related to NAFLD with diabetes and obese adult status.
Publisher
International Research and Publishing Academy
Reference29 articles.
1. Adiels, Martin, Marja Riitta Taskinen, and Jan Borén. 2008. “Fatty Liver, Insulin Resistance, and Dyslipidemia.” Current Diabetes Reports 8(1):60–64. doi: 10.1007/s11892-008-0011-4.
2. Carazo, Angel, Josefa León, Jorge Casado, Ana Gila, Sergio Delgado, Ana Martín, Laura Sanjuan, Trinidad Caballero, Jose Antonio Munoz, Rosa Quiles, Angeles Ruiz-Extremera, Luis Miguel Alcázar, and Javier Salmerón. 2011. “Hepatic Expression of Adiponectin Receptors Increases with Non-Alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1.” Obesity Surgery 21(4):492–500. doi: 10.1007/s11695-010-0353-2.
3. Fabbrini, Elisa, Shelby Sullivan, and Samuel Klein. 2010. “Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications.” Hepatology 51(2):679–89. doi: 10.1002/hep.23280.
4. Falck-Ytter, Y., Z. M. Younossi, G. Marchesini, and A. J. McCullough. 2001. “Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes.” Pp. 17–26 in Seminars in Liver Disease. Vol. 21. Copyright© 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New ….
5. Fierbinteanu-Braticevici, Carmen, Cristian Baicus, Laura Tribus, and Raluca Papacocea. 2011. “Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD).” Journal of Gastrointestinal and Liver Diseases 20(2):153–59.